Frazier Management LLC Sutro Biopharma, Inc. Transaction History

Frazier Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $13.8 Million - $27.2 Million	-1,776,479 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$14.25 - $23.53 $4.39 Million - $7.24 Million	307,816 Added 20.96%	1,776,479 $26.4 Million
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $7.89 Million - $10.5 Million	467,242 Added 46.66%	1,468,663 $27.7 Million
Q4 2020 Feb 11, 2021	BUY	$10.16 - $23.98 $10.2 Million - $24 Million	1,001,421 New	1,001,421 $21.7 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $101M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.